FDA Advisory Panel to Review Novel Antifungal Drug

Invasive aspergillosis is caused by molds that grow indoors and outside. Healthy people can breathe in aspergillus spores daily without any serious consequences, but individuals whose immune systems are already compromised are at risk for infection. These include patients who have undergone stem-cell or organ transplants, or who are undergoing chemotherapy for cancer. Mucormycosis, also known as zygomycosis, is triggered by fungi found on dead leaves and decaying wood. Risk factors of infection include uncontrolled diabetes, cancer, organ transplant, a low white blood cell count, and skin trauma. According to the CDC, infections among healthy individuals are rare, although they do occur. Isavuconazonium proposed for treating invasive aspergillosis and mucormycosis. http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/49659?xid=nl_mpt_DHE_2015-01-22&utm_content=&utm_medium=email&utm_campaign=DailyHeadlines&utm_source=ST&eun=g721819d0r&userid=721819&email=amydugan2%40gmail.com&mu_id=5883165&utm_term=Daily